HIV+Hep in the News

;

Blinken: PEPFAR ‘shows us what American diplomacy can do’

by | Dec 2, 2022

Secretary of State Antony Blinken on Friday noted the President’s Emergency Plan for AIDS Relief has saved more than 25 million lives since its launch in 2003. Blinken, who spoke at the Business Council for International Understanding’s World AIDS Day event at the Hay-Adams Hotel in D.C., said the more than $100 billion the U.S. has earmarked for PEPFAR over the last two decades has funded 70,000 new community health clinics, 3,000 new laboratories and the hiring of 340,000 health care workers.

read more

Advocacy group pushes $6B national PrEP program

by | Nov 29, 2022

“Missing from our nation’s effort to end HIV is a national PrEP program that covers the cost of the medications, associated labs, and prescriber time for those who lack health insurance along with the necessary provider and community outreach to increase PrEP uptake, particularly among the communities most impacted by HIV,” HIV+Hepatitis Policy Institute executive director Carl Schmid said in a statement Monday (Nov. 28). “We call on Congress to take immediate steps to correct this by including new funding to begin a national PrEP program at the CDC in the fiscal year 2023 spending bill currently being considered.”

read more

How do patient assistance programs work? The pros and cons of prescription coupons and more.

by | Nov 1, 2022

In August, the HIV+Hepatitis Policy Institute, the Diabetes Leadership Council, and the Diabetes Patient Advocacy Coalition filed a lawsuit challenging the federal rule that allows co-pay accumulators. Lawmakers in 14 states and Puerto Rico have outlawed accumulator programs, but those laws only apply to small group plans and marketplace plans because large group plans and self-funded employer plans are governed by the federal Employee Retirement Income Security Act of 1974 and not state laws.

read more

Is prescription copay assistance contributing to rising drug prices? Why buyers should beware.

by | Nov 1, 2022

“This practice is not only illegal but increases the cost of prescription drugs for millions of patients nationwide,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in a press release announcing the suit in August. “Nearly one in four Americans taking prescription drugs struggles to afford them. The growing practice of insurers and PBMs not counting copay assistance is one reason why.”

read more

Search

Pin It on Pinterest

Share This